NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

4 - Muntner Joshua B

Filed: 2026-04-16 AccNo: 0001651911-26-000004 Size: 6 KB
发布时间04/16 20:01 UTC
首次发现04/16 20:01 UTC
热度106.4
重要度74
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 493 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001651911-26-000004

Filing Date: 2026-04-16

Accepted: 2026-04-16 16:01:03

Documents: 1

Period of Report: 2026-04-06

Cardiff Oncology, Inc. ( Issuer ) CIK : 0001213037 (see all company filings) EIN. : 272004382 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | 4 | ownership.html | 4

1 | 4 | ownership.xml | 4